6 Realities of Genomic Research
By Dan Koboldt,
Mass Genomics
| 06. 19. 2015
Untitled Document
The rise of next-generation sequencing has worked wonders for the field of genetics and genomics. It’s also generated a considerable amount of hype about the power of genome sequencing, particularly the possibility of individualized medicine based on genetic information. The rapid advances in technology — most recently, the Illumina X Ten system — have made heretofore impossible large-scale whole-genome sequencing studies feasible. I’ve already written about some of the possible applications of inexpensive genome sequencing.
I’m as excited about this as anyone (with the possible exception of Illumina). Even so, we should keep in mind that not everything is unicorns and rainbows when it comes to genomic research. Here are some observations I’ve made about sequencing-empowered genomic research over the past few years.
1. There is never enough power
“Power” is a term that’s being discussed more and more as we plan large-scale sequencing studies of common disease. In essence, it answers the question, “What fraction of the associated variants can we detect with this study design, given the number of samples, inheritance pattern, penetrance, etc.?” Several years ago, when...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...